Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDEA trial of metoclopramide, dexamethasone, or palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting
2011-004446-17Phase 3Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing dexamethasone prophylaxis, metoclopramide prophylaxis and Aloxi prophylaxis (3 arms). Primary endpoint: Complete response during delayed phase. Started Dec 2011; status: terminated.
02
Drugs
palonosetrondexamethasonemetoclopramide
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2011-004446-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004446-17.